Loading...
Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with a grim overall 5-year survival rate of 5%. Advances in surgical techniques, critical care, molecular diagnosis, diagnostic imaging, endosonology and adjuvant therapy have improved outcomes; but still more needs to be...
Saved in:
| Published in: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Baishideng Publishing Group Inc
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309949/ https://ncbi.nlm.nih.gov/pubmed/25685272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v7.i2.6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|